An efficient GLP-1 expression system using two-step transcription amplification

Journal of Controlled Release

Volumn 115, Issue 3, 2006, Pages 316-321

  Lee, Minhyung ^a   Oh, Seungjoon ^b   Ahn, Cheol Hee ^c   Kim, Sung Wan ^d   Rhee, Byoung Doo ^e   Ko, Kyung Soo ^e  

^a Hanyang University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d UNIVERSITY OF UTAH   (United States)

^e Hallym Unversity College of Medicine   (South Korea)

Author keywords

Diabetes; Gene therapy; Glucagon like peptide 1; Two step transcription amplification

Indexed keywords

GENES; GENETIC ENGINEERING; GLUCOSE; POLYETHYLENES; PROTEINS; RNA;

DIABETES; GENE THERAPY; GLUCAGON LIKE PEPTIDE 1; TWO STEP TRANSCRIPTION AMPLIFICATION;

AMINO ACIDS;

GLUCAGON LIKE PEPTIDE 1; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; EMBRYO; GENE AMPLIFICATION; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONVIRAL GENE THERAPY; PLASMID; PRIORITY JOURNAL;

CELL LINE; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; IMINES; LUCIFERASES; LUMINESCENT AGENTS; PLASMIDS; POLYETHYLENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 33750345199     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.07.017     Document Type: Article

References (22)

1. Holst J.J. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 107 (1994) 1848-1855
2. Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., and Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 91 (1993) 301-307
3. Perfetti R., and Merkel P. Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function. Eur. J. Endocrinol. 143 (2000) 717-725
4. Fehmann H.C., Goke R., and Goke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr. Rev. 16 (1995) 390-410
5. Nauck M.A., Sauerwald A., Ritzel R., Holst J.J., and Schmiegel W. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure. Diabetes Care 21 (1998) 1925-1931
6. Rachman J., Barrow B.A., Levy J.C., and Turner R.C. Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM. Diabetologia 40 (1997) 205-211
7. Szayna M., Doyle M.E., Betkey J.A., Holloway H.W., Spencer R.G., Greig N.H., and Egan J.M. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology 141 (2000) 1936-1941
8. Oh S., Lee M., Ko K.S., Choi S., and Kim S.W. GLP-1 gene delivery for the treatment of type 2 diabetes. Molec. Ther. 7 (2003) 478-483
9. Zhang L., Adams J.Y., Billick E., Ilagan R., Iyer M., Le K., Smallwood A., Gambhir S.S., Carey M., and Wu L. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Molec. Ther. 5 (2002) 223-232
10. Iyer M., Salazar F.B., Lewis X., Zhang L., Carey M., Wu L., and Gambhir S.S. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Molec. Ther. 10 (2004) 545-552
11. Tang Y., Schmitt-Ott K., Qian K., Kagiyama S., and Phillips M.I. Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases. Methods 28 (2002) 259-266
12. Tang Y., Jackson M., Qian K., and Phillips M.I. Hypoxia inducible double plasmid system for myocardial ischemia gene therapy. Hypertension 39 (2002) 695-698
13. Phillips M.I., Tang Y., Schmidt-Ott K., Qian K., and Kagiyama S. Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension 39 (2002) 651-655
14. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., and Demeneix B.A. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum. Gene Ther. 7 (1996) 1947-1954
15. Lemkine G.F., Goula D., Becker N., Paleari L., Levi G., and Demeneix B.A. Optimisation of polyethylenimine-based gene delivery to mouse brain. J. Drug Target. 7 (1999) 305-312
16. Turunen M.P., Hiltunen M.O., Ruponen M., Virkamaki L., Szoka Jr. F.C., Urtti A., and Yla-Herttuala S. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther. 6 (1999) 6-11
17. Wightman L., Patzelt E., Wagner E., and Kircheis R. Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells. J. Drug Target. 7 (1999) 293-303
18. Nguyen H.K., Lemieux P., Vinogradov S.V., Gebhart C.L., Guerin N., Paradis G., Bronich T.K., Alakhov V.Y., and Kabanov A.V. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7 (2000) 126-138
19. Lee M., Rentz J., Bikram M., Han S., Bull D.A., and Kim S.W. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther. 10 (2003) 1535-1542
20. Xu Z.L., Mizuguchi H., Ishii-Watabe A., Uchida E., Mayumi T., and Hayakawa T. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 272 (2001) 149-156
21. Xu Z.L., Mizuguchi H., Ishii-Watabe A., Uchida E., Mayumi T., and Hayakawa T. Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. J. Control. Release 81 (2002) 155-163
22. Clamme J.P., Azoulay J., and Mely Y. Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys. J. 84 (2003) 1960-1968